+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Point of Care Testing Market Research Report by Product (Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, and Fertility & Pregnancy Testing Kits), End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 232 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 4968870
UP TO OFF until Mar 31st 2023
The Global Point of Care Testing Market size was estimated at USD 25.67 billion in 2022, USD 28.90 billion in 2023, and is projected to grow at a CAGR of 12.73% to reach USD 66.98 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Point of Care Testing Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Point of Care Testing Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Point of Care Testing Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Point of Care Testing Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Point of Care Testing Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits, Glucose Monitoring Kits, Haematology Testing Kits, and Infectious Disease Testing Kits.
  • Based on End-User, the market is studied across Ambulatory Care, Home Care, Hospitals or Critical Care, Outpatient Healthcare, and Research Laboratories.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Point of Care Testing Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Point of Care Testing Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Point of Care Testing Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Point of Care Testing Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Point of Care Testing Market, including Abbott Laboratories, ACON Laboratories, Inc., Alere Inc, Ativa Medical Corporation, Becton, Dickinson, and Company, BIOMERIEUX SA, Chembio Diagnostics, Danaher Corporation, EKF Diagnostics Holdings plc, Henry Schein, Inc, Informa PLC, Instrumentation Laboratory Company, Johnson and Johnson Service, Inc., Medtronic plc, Polymer Technology Systems, Inc., QIAGEN GmbH, Roche Holding AG, Siemens AG, Sienco, Inc., and WerfenLife, S.A..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Point of Care Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Point of Care Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Point of Care Testing Market?
4. What is the competitive strategic window for opportunities in the Global Point of Care Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Point of Care Testing Market?
6. What is the market share of the leading vendors in the Global Point of Care Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Point of Care Testing Market?
Frequently Asked Questions about the Global Point of Care Testing Market

What is the estimated value of the Global Point of Care Testing Market?

The Global Point of Care Testing Market was estimated to be valued at $25.67 Billion in 2022.

What is the growth rate of the Global Point of Care Testing Market?

The growth rate of the Global Point of Care Testing Market is 12.7%, with an estimated value of $66.98 Billion by 2030.

What is the forecasted size of the Global Point of Care Testing Market?

The Global Point of Care Testing Market is estimated to be worth $66.98 Billion by 2030.

Who are the key companies in the Global Point of Care Testing Market?

Key companies in the Global Point of Care Testing Market include Abbott Laboratories, ACON Laboratories, Inc., Alere Inc, Ativa Medical Corporation, Becton, Dickinson, and Company, BIOMERIEUX SA, Chembio Diagnostics, Danaher Corporation and Henry Schein, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chronic and infectious diseases globally
5.1.1.2. Favorable government policies for introduction of POC testing
5.1.1.3. Potential demand for enhanced patient-centric care with new advanced testing kits
5.1.2. Restraints
5.1.2.1. Relatively high cost involved in product development
5.1.3. Opportunities
5.1.3.1. Surge in research and development investment by manufacturers
5.1.3.2. Technological advancements in POC testing
5.1.4. Challenges
5.1.4.1. Time-consuming regulatory policies for approval of POC testing kits
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Point of Care Testing Market, by Product
6.1. Introduction
6.2. Cardio-Metabolic Monitoring Kits
6.3. Cholesterol Test Strips
6.4. Fertility & Pregnancy Testing Kits
6.5. Glucose Monitoring Kits
6.6. Haematology Testing Kits
6.7. Infectious Disease Testing Kits

7. Point of Care Testing Market, by End-User
7.1. Introduction
7.2. Ambulatory Care
7.3. Home Care
7.4. Hospitals or Critical Care
7.5. Outpatient Healthcare
7.6. Research Laboratories

8. Americas Point of Care Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Point of Care Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Point of Care Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. ACON Laboratories, Inc.
12.3. Alere Inc
12.4. Ativa Medical Corporation
12.5. Becton, Dickinson, and Company
12.6. BIOMERIEUX SA
12.7. Chembio Diagnostics
12.8. Danaher Corporation
12.9. EKF Diagnostics Holdings plc
12.10. Henry Schein, Inc
12.11. Informa PLC
12.12. Instrumentation Laboratory Company
12.13. Johnson and Johnson Service, Inc.
12.14. Medtronic plc
12.15. Polymer Technology Systems, Inc.
12.16. QIAGEN GmbH
12.17. Roche Holding AG
12.18. Siemens AG
12.19. Sienco, Inc.
12.20. WerfenLife, S.A.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL POINT OF CARE TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL POINT OF CARE TESTING MARKET DYNAMICS
FIGURE 11. GLOBAL POINT OF CARE TESTING MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY & PREGNANCY TESTING KITS, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, 2018-2030 (USD BILLION)
FIGURE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, 2018-2030 (USD BILLION)
FIGURE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, 2018-2030 (USD BILLION)
FIGURE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 22. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 23. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD BILLION)
FIGURE 25. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, 2018-2030 (USD BILLION)
FIGURE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, 2018-2030 (USD BILLION)
FIGURE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, 2018-2030 (USD BILLION)
FIGURE 28. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD BILLION)
FIGURE 29. AMERICAS POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 30. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 31. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 32. AMERICAS POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 33. ARGENTINA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 34. BRAZIL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 35. CANADA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 36. MEXICO POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 37. UNITED STATES POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 38. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 39. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 40. UNITED STATES POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 41. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 42. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 43. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 44. ASIA-PACIFIC POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 45. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 46. CHINA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 47. INDIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 48. INDONESIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 49. JAPAN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 50. MALAYSIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 51. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 52. SINGAPORE POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 53. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 54. TAIWAN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 55. THAILAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 56. VIETNAM POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 61. DENMARK POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 62. EGYPT POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 63. FINLAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 64. FRANCE POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 65. GERMANY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 66. ISRAEL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 67. ITALY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 68. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 69. NIGERIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. NORWAY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. POLAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. QATAR POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. RUSSIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. SPAIN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. SWEDEN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 78. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 79. TURKEY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 80. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 81. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 82. GLOBAL POINT OF CARE TESTING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 83. GLOBAL POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 84. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL POINT OF CARE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY & PREGNANCY TESTING KITS, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY & PREGNANCY TESTING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY & PREGNANCY TESTING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 29. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, 2018-2030 (USD BILLION)
TABLE 30. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 32. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, 2018-2030 (USD BILLION)
TABLE 33. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 34. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 35. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, 2018-2030 (USD BILLION)
TABLE 36. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 37. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 38. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD BILLION)
TABLE 39. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 40. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 41. AMERICAS POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 42. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 43. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 44. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 45. ARGENTINA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 46. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 47. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 48. BRAZIL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 49. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 50. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 51. CANADA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 52. CANADA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 53. CANADA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 54. MEXICO POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 55. MEXICO POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 56. MEXICO POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 57. UNITED STATES POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 58. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 59. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 60. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 61. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 62. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 63. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 64. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 65. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 66. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 67. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 68. CHINA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 69. CHINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 70. CHINA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 71. INDIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 72. INDIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 73. INDIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 74. INDONESIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 75. INDONESIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 76. INDONESIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 77. JAPAN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 78. JAPAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 79. JAPAN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 80. MALAYSIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 81. MALAYSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 82. MALAYSIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 83. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 84. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 85. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 86. SINGAPORE POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 87. SINGAPORE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 88. SINGAPORE POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 89. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 90. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 91. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 92. TAIWAN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 93. TAIWAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 94. TAIWAN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 95. THAILAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 96. THAILAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 97. THAILAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 98. VIETNAM POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 99. VIETNAM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 100. VIETNAM POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 105. DENMARK POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 106. DENMARK POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 107. DENMARK POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 108. EGYPT POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 109. EGYPT POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 110. EGYPT POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 111. FINLAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 112. FINLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 113. FINLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 114. FRANCE POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 115. FRANCE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 116. FRANCE POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 117. GERMANY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 118. GERMANY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 119. GERMANY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 120. ISRAEL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 121. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 122. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 123. ITALY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 124. ITALY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 125. ITALY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 126. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 128. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 129. NIGERIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 130. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 131. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 132. NORWAY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 133. NORWAY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 134. NORWAY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 135. POLAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 136. POLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 137. POLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 138. QATAR POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. QATAR POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 140. QATAR POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 141. RUSSIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 142. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 143. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 144. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 145. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 146. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 147. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 148. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 149. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 150. SPAIN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 151. SPAIN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 152. SPAIN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 153. SWEDEN POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 154. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 155. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 156. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 157. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 158. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 159. TURKEY POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 160. TURKEY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 161. TURKEY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 162. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 163. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 164. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 165. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 166. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 167. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 168. GLOBAL POINT OF CARE TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 169. GLOBAL POINT OF CARE TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 170. GLOBAL POINT OF CARE TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 171. GLOBAL POINT OF CARE TESTING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 172. GLOBAL POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 173. GLOBAL POINT OF CARE TESTING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 174. GLOBAL POINT OF CARE TESTING MARKET MERGER & ACQUISITION
TABLE 175. GLOBAL POINT OF CARE TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 176. GLOBAL POINT OF CARE TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 177. GLOBAL POINT OF CARE TESTING MARKET INVESTMENT & FUNDING
TABLE 178. GLOBAL POINT OF CARE TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 179. GLOBAL POINT OF CARE TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alere Inc
  • Ativa Medical Corporation
  • Becton, Dickinson, and Company
  • BIOMERIEUX SA
  • Chembio Diagnostics
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • Henry Schein, Inc
  • Informa PLC
  • Instrumentation Laboratory Company
  • Johnson and Johnson Service, Inc.
  • Medtronic plc
  • Polymer Technology Systems, Inc.
  • QIAGEN GmbH
  • Roche Holding AG
  • Siemens AG
  • Sienco, Inc.
  • WerfenLife, S.A.

Methodology

Loading
LOADING...